Hyliion Holdings Corp.HYLNNYSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank32
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P32
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 2025-6.19%
Q3 2025-92.51%
Q2 2025-17.11%
Q1 20258.59%
Q4 202419.03%
Q3 202413.85%
Q2 20244.30%
Q1 2024-9.12%
Q4 2023-65.09%
Q3 2023-8.47%
Q2 202331.17%
Q1 2023-4.16%
Q4 2022-58.57%
Q3 2022162.64%
Q2 202226.88%
Q1 2022-9.10%
Q4 2021-4.19%
Q3 202135.56%
Q2 202143.47%
Q1 2021109.05%
Q4 202053.45%
Q3 202013.90%
Q2 2020-4.38%
Q1 2020-71.18%
Q4 20190.00%
Q3 2019-100.00%
Q2 20190.00%
Q1 20190.00%
Q4 20180.00%